Insider Selling: HeartWare International Insider Sells 2,179 Shares of Stock (HTWR)
HeartWare International (NASDAQ:HTWR) Insider Jeffrey Larose sold 2,179 shares of HeartWare International stock on the open market in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $98.48, for a total value of $214,587.92. Following the transaction, the insider now directly owns 4,925 shares in the company, valued at approximately $485,014. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
A number of analysts have recently weighed in on HTWR shares. Analysts at Barclays reiterated an “overweight” rating on shares of HeartWare International in a research note to investors on Thursday, January 9th. They now have a $110.00 price target on the stock, up previously from $100.00. Separately, analysts at JPMorgan Chase & Co. raised their price target on shares of HeartWare International from $125.00 to $131.00 in a research note to investors on Monday, December 16th. Finally, analysts at Canaccord Genuity raised their price target on shares of HeartWare International from $110.00 to $115.00 in a research note to investors on Tuesday, December 3rd. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $99.42.
Shares of HeartWare International (NASDAQ:HTWR) traded down 1.28% on Tuesday, hitting $95.07. 243,521 shares of the company’s stock traded hands. HeartWare International has a 52 week low of $69.31 and a 52 week high of $105.84. The stock has a 50-day moving average of $97.90 and a 200-day moving average of $86.39. The company’s market cap is $1.565 billion.
HeartWare International (NASDAQ:HTWR) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.69) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.83) by $0.14. The company had revenue of $54.80 million for the quarter, compared to the consensus estimate of $49.40 million. On average, analysts predict that HeartWare International will post $-3.11 earnings per share for the current fiscal year.
Heartware International, Inc (NASDAQ:HTWR) develops and manufactures small implantable heart pumps, or ventricular assist devices, for the treatment of advanced heart failure.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.